Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Post Menopausal Breast Cancer
Interventions: DRUG: everolimus|DRUG: exemestane
Sponsor: Novartis Pharmaceuticals